{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:08:39Z","timestamp":1793315319165,"version":"4.5.0"},"reference-count":91,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Dapansutrile, an orally active and selective NLRP3 inflammasome inhibitor, exerts its effects by directly binding to the NLRP3 NACHT domain. This action disrupts inflammasome assembly and caspase-1 activation, thereby inhibiting the maturation and release of the pro-inflammatory cytokines IL-1\u03b2 and IL-18. Beyond this core inhibition, dapansutrile modulates immune cell chemotaxis and inhibits pyroptosis. Preclinical and clinical studies demonstrate its efficacy in mitigating pathology in diverse conditions, including gouty arthritis, cardiovascular diseases, neurodegenerative disorders, inflammatory bowel disease, and periodontitis. A favorable safety profile distinguishes it from other NLRP3 inhibitors like MCC950, with no significant hepatotoxicity reported in trials. Furthermore, dapansutrile exhibits synergistic effects when combined with agents such as lonafarnib or immune checkpoint inhibitors, enhancing anti-inflammatory and anti-tumor responses. This review consolidates evidence on dapansutrile\u2019s molecular mechanisms, therapeutic applications, and biosafety, highlighting its potential as a novel, well-tolerated, and versatile anti-inflammatory agent. Future research should focus on optimizing its delivery, particularly to the central nervous system, and leveraging artificial intelligence to predict effective drug combinations.<\/jats:p>","DOI":"10.3389\/fphar.2025.1731165","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T06:39:38Z","timestamp":1764743978000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Dapansutrile in multidisciplinary therapeutic applications: mechanisms and clinical perspectives"],"prefix":"10.3389","volume":"16","author":[{"given":"Fuwei","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"102257","DOI":"10.1016\/j.arr.2024.102257","article-title":"Circulating biomarkers of inflammaging and alzheimer's disease to track age-related trajectories of dementia: can we develop a clinically relevant composite combination?","volume":"96","author":"Abbatecola","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"109756","DOI":"10.1016\/j.compbiomed.2025.109756","article-title":"Utilizing machine learning for predicting drug release from polymeric drug delivery systems","volume":"188","author":"Aghajanpour","year":"2025","journal-title":"Comput. Biol. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"118026","DOI":"10.1016\/j.biopha.2025.118026","article-title":"Dapansutrile mitigates concanavalin A-induced autoimmune hepatitis: involvement of NLRP3\/IL-1\u03b2 and JNK\/p38 MAPK pathways","volume":"186","author":"Alenezi","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.3390\/molecules26123534","article-title":"Preservation of contractile reserve and diastolic function by inhibiting the NLRP3 inflammasome with OLT1177(\u00ae) (dapansutrile) in a mouse model of severe ischemic cardiomyopathy due to non-reperfused anterior Wall myocardial infarction","volume":"26","author":"Aliaga","year":"2021","journal-title":"Molecules"},{"key":"B5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12974-023-02830-w","article-title":"Pharmacologic inhibition of NLRP3 reduces the levels of \u03b1-synuclein and protects dopaminergic neurons in a model of Parkinson's disease","volume":"20","author":"Amo-Aparicio","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41580-025-00837-0","article-title":"Mechanistic insights into gasdermin-mediated pyroptosis","volume":"26","author":"Bai","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41467-022-35343-w","article-title":"Machine learning models to accelerate the design of polymeric long-acting injectables","volume":"14","author":"Bannigan","year":"2023","journal-title":"Nat. Commun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4212\/cjhp.v74i4.3199","article-title":"Optimizing thiopurine therapy with a xanthine oxidase inhibitor in patients with systemic autoimmune diseases: a single-centre experience","volume":"74","author":"Belhocine","year":"2021","journal-title":"Can. J. Hosp. Pharm."},{"key":"B9","doi-asserted-by":"publisher","first-page":"114147","DOI":"10.1016\/j.bcp.2020.114147","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective","volume":"180","author":"Bindu","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"105699","DOI":"10.1016\/j.antiviral.2023.105699","article-title":"Shikonin, an inhibitor of inflammasomes, inhibits Epstein-Barr virus reactivation","volume":"217","author":"Borde","year":"2023","journal-title":"Antivir. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.tips.2025.04.007","article-title":"Targeting the NLRP3 inflammasome for inflammatory disease therapy","volume":"46","author":"Cabral","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"765474","DOI":"10.3389\/fmed.2021.765474","article-title":"Treatment of inflammatory bowel disease: a comprehensive review","volume":"8","author":"Cai","year":"","journal-title":"Front. Med. (Lausanne)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"809433","DOI":"10.3389\/fnagi.2021.809433","article-title":"Salidroside ameliorates Alzheimer's Disease by targeting NLRP3 inflammasome-mediated pyroptosis","volume":"13","author":"Cai","year":"","journal-title":"Front. Aging Neurosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"990469","DOI":"10.3389\/fphys.2022.990469","article-title":"Exploring the mechanism of action of dapansutrile in the treatment of gouty arthritis based on molecular docking and molecular dynamics","volume":"13","author":"Cao","year":"2022","journal-title":"Front. Physiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1128\/mmbr.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"7334","DOI":"10.1039\/d4tb00705k","article-title":"Dapansutrile OLT1177 suppresses foreign body response inflammation while preserving vascularisation of implanted materials","volume":"12","author":"Chan","year":"2024","journal-title":"J. Mater Chem. B"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s00018-017-2720-9","article-title":"Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma","volume":"75","author":"Chen","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1109\/tcbb.2022.3224734","article-title":"A drug combination prediction framework based on graph convolutional network and heterogeneous information","volume":"20","author":"Chen","year":"2023","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinform"},{"key":"B19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1021\/acs.jmedchem.0c01924","article-title":"Development of novel tetrahydroquinoline inhibitors of NLRP3 inflammasome for potential treatment of DSS-Induced mouse colitis","volume":"64","author":"Dai","year":"2021","journal-title":"J. Med. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/cells12020294","article-title":"Dexamethasone and OLT1177 cooperate in the reduction of melanoma growth by inhibiting STAT3 functions","volume":"12","author":"Dinarello","year":"2023","journal-title":"Cells"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1021\/acsptsci.4c00061","article-title":"Pharmacological Analysis of NLRP3 Inflammasome Inhibitor Sodium [(1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)carbamoyl] [(1-methyl-1H-pyrazol-4-yl)({[(2S)-oxolan-2-yl]methyl})sulfamoyl]azanide in Cellular and Mouse Models of Inflammation Provides a Translational Framework","volume":"7","author":"Doedens","year":"2024","journal-title":"ACS Pharmacol. and Transl. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"119974","DOI":"10.1016\/j.lfs.2021.119974","article-title":"The NLRP3 inhibitor dapansutrile attenuates folic acid induced nephrotoxicity via inhibiting inflammasome\/caspase-1\/IL axis and regulating autophagy\/proliferation","volume":"285","author":"Elsayed","year":"2021","journal-title":"Life Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"115047","DOI":"10.1016\/j.biopha.2023.115047","article-title":"Daphnetin ameliorates PM2.5-induced airway inflammation by inhibiting NLRP3 inflammasome-mediated pyroptosis in CS-exposed mice","volume":"165","author":"Fan","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1182\/blood.v98.3.525","article-title":"H ferritin knockout mice: a model of hyperferritinemia in the absence of iron overload","volume":"98","author":"Ferreira","year":"2001","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1565422","DOI":"10.3389\/fphar.2025.1565422","article-title":"Suppressing chondrocyte cuproptosis by syringaresinol-4-O-beta-d-glucoside alleviates gouty arthritis","volume":"16","author":"Fu","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/1440-1681.13686","article-title":"Cold-inflammaging: when a state of homeostatic-imbalance associated with aging precedes the low-grade pro-inflammatory-state (inflammaging): meaning, evolution, inflammaging phenotypes","volume":"49","author":"Giunta","year":"2022","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1089\/hum.2016.003","article-title":"E-Prostanoid 2 receptor overexpression promotes mesenchymal stem cell attenuated lung injury","volume":"27","author":"Han","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"14897","DOI":"10.1021\/acs.jmedchem.3c01398","article-title":"Discovery of clinical candidate NT-0796, a brain-penetrant and highly potent NLRP3 inflammasome inhibitor for neuroinflammatory disorders","volume":"66","author":"Harrison","year":"2023","journal-title":"J. Med. Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2963540","DOI":"10.1155\/2020\/2963540","article-title":"Ellagic acid protects dopamine neurons via inhibition of NLRP3 inflammasome activation in Microglia","volume":"2020","author":"He","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"17929","DOI":"10.1021\/acsnano.5c04810","article-title":"Active learning-based prediction of drug combination efficacy","volume":"19","author":"Jin","year":"2025","journal-title":"ACS Nano"},{"key":"B32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cytogfr.2024.08.003","article-title":"Cytokines on the way to secretion","volume":"79","author":"Kaminska","year":"2024","journal-title":"Cytokine Growth Factor Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"22271","DOI":"10.1039\/d5nr01741f","article-title":"Leveraging ensemble machine learning models (XGBoost and random forest) and genetic algorithms to predict factors contributing to the liposomal entrapment of therapeutics","volume":"17","author":"Khodadadi","year":"2025","journal-title":"Nanoscale"},{"key":"B34","doi-asserted-by":"publisher","first-page":"903834","DOI":"10.3389\/fimmu.2022.903834","article-title":"The NLRP3 inflammasome inhibitor dapansutrile attenuates cyclophosphamide-induced interstitial cystitis","volume":"13","author":"Kiran","year":"2022","journal-title":"Front. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/s0140-6736(24)02322-5","article-title":"Osteoarthritis","volume":"405","author":"Kloppenburg","year":"2025","journal-title":"Lancet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/s2665-9913(20)30065-5","article-title":"Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial","volume":"2","author":"Kl\u00fcck","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e1471","DOI":"10.1002\/ctm2.1471","article-title":"A randomized, double-blind phase 1b study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of the NLRP3 inhibitor selnoflast in patients with moderate to severe active ulcerative colitis","volume":"13","author":"Klughammer","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4058","DOI":"10.3390\/nu13114058","article-title":"Potential nutrients from natural and synthetic sources targeting Inflammaging-A review of literature, clinical data and patents","volume":"13","author":"Koppula","year":"2021","journal-title":"Nutrients"},{"key":"B39","doi-asserted-by":"publisher","first-page":"175091","DOI":"10.1016\/j.ejphar.2022.175091","article-title":"Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome","volume":"928","author":"Li","year":"","journal-title":"Eur. J. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"110229","DOI":"10.1016\/j.cbi.2022.110229","article-title":"Aluminum activates NLRP3 inflammasome-mediated pyroptosis via reactive oxygen species to induce liver injury in mice","volume":"368","author":"Li","year":"","journal-title":"Chem. Biol. Interact."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.7150\/thno.70701","article-title":"Phosphorus dendron nanomicelles as a platform for combination anti-inflammatory and antioxidative therapy of acute lung injury","volume":"12","author":"Li","year":"","journal-title":"Theranostics"},{"key":"B42","doi-asserted-by":"publisher","first-page":"118712","DOI":"10.1016\/j.carbpol.2021.118712","article-title":"In silico formulation prediction of drug\/cyclodextrin\/polymer ternary complexes by machine learning and molecular modeling techniques","volume":"275","author":"Li","year":"","journal-title":"Carbohydr. Polym."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1111\/bph.16036","article-title":"Discovery of alantolactone as a naturally occurring NLRP3 inhibitor to alleviate NLRP3-driven inflammatory diseases in mice","volume":"180","author":"Li","year":"","journal-title":"Br. J. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"12966","DOI":"10.1021\/acs.jmedchem.3c00894","article-title":"Novel sulfonylurea-based NLRP3 inflammasome inhibitor for efficient treatment of Nonalcoholic steatohepatitis, endotoxic shock, and colitis","volume":"66","author":"Li","year":"","journal-title":"J. Med. Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e07764","DOI":"10.1002\/advs.202507764","article-title":"Protein spatial structure meets artificial intelligence: revolutionizing drug synergy-antagonism in precision medicine","volume":"12","author":"Lin","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"32145","DOI":"10.1073\/pnas.2009680117","article-title":"The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer's disease","volume":"117","author":"Lonnemann","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B47","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.canlet.2020.10.024","article-title":"NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma","volume":"497","author":"Lu","year":"2021","journal-title":"Cancer Lett."},{"key":"B48","doi-asserted-by":"publisher","first-page":"117783","DOI":"10.1016\/j.ejmech.2025.117783","article-title":"Discovery of novel non-sulfonylurea NLRP3 inflammasome inhibitors for the treatment of multiple inflammatory diseases","volume":"295","author":"Lv","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B50","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13075-018-1664-2","article-title":"NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis","volume":"20","author":"Marchetti","year":"","journal-title":"Arthritis Res. Ther."},{"key":"B51","doi-asserted-by":"publisher","first-page":"14721","DOI":"10.1021\/acs.jmedchem.2c01250","article-title":"Overcoming preclinical safety obstacles to discover (S)-N-((1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)carbamoyl)-6-(methylamino)-6,7-dihydro-5H-pyrazolo[5,1-b] [1,3]oxazine-3-sulfonamide (GDC-2394): a potent and selective NLRP3 inhibitor","volume":"65","author":"McBride","year":"2022","journal-title":"J. Med. Chem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"458","DOI":"10.2174\/1568026615666150114161358","article-title":"Lipoic Acid: its antioxidant and anti-inflammatory role and clinical applications","volume":"15","author":"Moura","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e14272","DOI":"10.1111\/acel.14272","article-title":"The NLRP3 inhibitor Dapansutrile improves the therapeutic action of lonafarnib on progeroid mice","volume":"23","author":"Muela-Zarzuela","year":"2024","journal-title":"Aging Cell"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1384996","DOI":"10.3389\/fcvm.2024.1384996","article-title":"Inflammaging, immunosenescence, and cardiovascular aging: insights into long COVID implications","volume":"11","author":"Muller","year":"2024","journal-title":"Front. Cardiovasc Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.3390\/biomedicines10092133","article-title":"Neuro-Inflammaging and psychopathological distress","volume":"10","author":"Murdaca","year":"2022","journal-title":"Biomedicines"},{"key":"B56","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41423-025-01284-9","article-title":"Updated insights into the molecular networks for NLRP3 inflammasome activation","volume":"22","author":"Paik","year":"2025","journal-title":"Cell Mol. Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/cpdd.1162","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral NLRP3 inflammasome inhibitor ZYIL1: First-in-Human phase 1 studies (single ascending dose and multiple ascending dose)","volume":"12","author":"Parmar","year":"2023","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"B58","doi-asserted-by":"publisher","first-page":"8618","DOI":"10.1038\/s41598-018-26775-w","article-title":"MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice","volume":"8","author":"Perera","year":"2018","journal-title":"Sci. Rep."},{"key":"B59","doi-asserted-by":"publisher","first-page":"5096","DOI":"10.1039\/c9tb02778e","article-title":"Optimisation and feature selection of poly-beta-amino-ester as a drug delivery system for cartilage","volume":"8","author":"Perni","year":"2020","journal-title":"J. Mater Chem. B"},{"key":"B60","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00702-010-0428-1","article-title":"Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy","volume":"117","author":"Qian","year":"2010","journal-title":"J. Neural Transm. (Vienna)"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.4161\/onci.22089","article-title":"A TLR4-interacting peptide inhibits lipopolysaccharide-stimulated inflammatory responses, migration and invasion of colon cancer SW480 cells","volume":"1","author":"Rakhesh","year":"2012","journal-title":"OncoImmunology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1093\/cvr\/cvz161","article-title":"Small animal models of heart failure","volume":"115","author":"Riehle","year":"2019","journal-title":"Cardiovasc Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"119123","DOI":"10.1016\/j.lfs.2021.119123","article-title":"BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R\/NLRP3 and MyD88\/NF-\u03baB signaling in DSS-induced colitis in rats","volume":"270","author":"Saber","year":"2021","journal-title":"Life Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10557-014-6559-0","article-title":"Tadalafil prevents acute heart failure with reduced ejection fraction in mice","volume":"28","author":"Salloum","year":"2014","journal-title":"Cardiovasc Drugs Ther."},{"key":"B65","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41586-019-1551-2","article-title":"DDX3X acts as a live-or-die checkpoint in stressed cells by regulating NLRP3 inflammasome","volume":"573","author":"Samir","year":"2019","journal-title":"Nature"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.3389\/fimmu.2019.02578","article-title":"OLT1177 (Dapansutrile), a selective NLRP3 inflammasome inhibitor, ameliorates experimental Autoimmune Encephalomyelitis pathogenesis","volume":"10","author":"Sanchez-Fernandez","year":"2019","journal-title":"Front. Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"21811","DOI":"10.1039\/c9nr05070a","article-title":"Designing nanoparticle release systems for drug-vitamin cancer co-therapy with multiplicative perturbation-theory machine learning (PTML) models","volume":"11","author":"Santana","year":"2019","journal-title":"Nanoscale"},{"key":"B68","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41586-019-1295-z","article-title":"Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome","volume":"570","author":"Sharif","year":"2019","journal-title":"Nature"},{"key":"B69","doi-asserted-by":"publisher","first-page":"5529","DOI":"10.1021\/acs.jmedchem.4c02759","article-title":"Discovery of DFV890, a potent sulfonimidamide-containing NLRP3 inflammasome inhibitor","volume":"68","author":"Shen","year":"2025","journal-title":"J. Med. Chem."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1378324","DOI":"10.3389\/fchem.2024.1378324","article-title":"The state-of-art polyurethane nanoparticles for drug delivery applications","volume":"12","author":"Song","year":"2024","journal-title":"Front. Chem."},{"key":"B71","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.molimm.2018.03.002","article-title":"Vasoactive intestinal peptide overexpression mediated by lentivirus attenuates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation","volume":"97","author":"Sun","year":"2018","journal-title":"Mol. Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"117644","DOI":"10.1016\/j.ejmech.2025.117644","article-title":"Scaffold hopping-based structural modification of tranilast led to the identification of HNW005 as a promising NLRP3 inflammasome and URAT1 dual inhibitor for the treatment of gouty arthritis","volume":"292","author":"Sun","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"B73","doi-asserted-by":"publisher","first-page":"9603271221145401","DOI":"10.1177\/09603271221145401","article-title":"Dapansutrile ameliorated chondrocyte inflammation and osteoarthritis through suppression of MAPK signaling pathway","volume":"41","author":"Tang","year":"2022","journal-title":"Hum. Exp. Toxicol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e2000915118","DOI":"10.1073\/pnas.2000915118","article-title":"Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion","volume":"118","author":"Tengesdal","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.cell.2016.10.018","article-title":"Host and environmental factors influencing individual human cytokine responses","volume":"167","author":"Ter Horst","year":"2016","journal-title":"Cell"},{"key":"B76","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/fjc.0000000000000658","article-title":"The NLRP3 inflammasome inhibitor, OLT1177 (Dapansutrile), reduces infarct size and preserves contractile function after ischemia reperfusion injury in the mouse","volume":"73","author":"Toldo","year":"2019","journal-title":"J. Cardiovasc Pharmacol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/cpt.3732","article-title":"An Integrated AI-PBPK platform for predicting drug in vivo fate and tissue distribution in human and inter-species extrapolation","volume":"118","author":"Wang","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"key":"B78","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/fjc.0000000000000931","article-title":"Phase 1B, randomized, Double-Blinded, dose escalation, Single-Center, repeat dose safety and pharmacodynamics Study of the oral NLRP3 inhibitor dapansutrile in subjects with NYHA II-III systolic heart failure","volume":"77","author":"Wohlford","year":"2020","journal-title":"J. Cardiovasc Pharmacol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/jcpe.14144","article-title":"Hyperuricemia exacerbates experimental periodontitis via uric acid-induced periodontal inflammation and oxidative stress","volume":"52","author":"Wu","year":"2025","journal-title":"J. Clin. Periodontol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1080\/1061186x.2023.2220083","article-title":"Reduction of systemic exposure and side effects by intra-articular injection of anti-inflammatory agents for osteoarthritis: what is the safer strategy?","volume":"31","author":"Xie","year":"2023","journal-title":"J. Drug Target"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/s41418-022-00947-8","article-title":"Ubiquitination of NLRP3 by gp78\/Insig-1 restrains NLRP3 inflammasome activation","volume":"29","author":"Xu","year":"2022","journal-title":"Cell Death Differ."},{"key":"B82","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fnagi.2020.00078","article-title":"Pharmacological inhibition of HDAC6 attenuates NLRP3 inflammatory response and protects dopaminergic neurons in experimental models of parkinson's disease","volume":"12","author":"Yan","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.hlc.2023.09.017","article-title":"Dapansutrile ameliorates atrial inflammation and vulnerability to atrial fibrillation in HFpEF rats","volume":"33","author":"Yang","year":"2024","journal-title":"Heart Lung Circ."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.joca.2025.06.008","article-title":"Emapunil relieves osteoarthritis by regulating the CD14\/TLR4\/LY96 pathway in synovial macrophages through translocator protein 18 kDa","volume":"33","author":"Yin","year":"2025","journal-title":"Osteoarthr. Cartil."},{"key":"B85","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11926-023-01128-3","article-title":"Pipeline therapies for gout","volume":"26","author":"Yip","year":"2024","journal-title":"Curr. Rheumatol. Rep."},{"key":"B86","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.2147\/jir.S509168","article-title":"NLRP3 mediates NOXs-Induced iron overload and inflammation but not oxidative damage in colons of DSS-treated mice","volume":"18","author":"Yu","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"e12694","DOI":"10.1111\/acel.12694","article-title":"Anti-inflammaging effects of human alpha-1 antitrypsin","volume":"17","author":"Yuan","year":"2018","journal-title":"Aging Cell"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.14336\/ad.2024.0922","article-title":"Mechanisms underlying vascular inflammaging: current insights and potential treatment approaches","volume":"16","author":"Zeng","year":"2024","journal-title":"Aging Dis."},{"key":"B89","doi-asserted-by":"publisher","first-page":"172653","DOI":"10.1016\/j.scitotenv.2024.172653","article-title":"NLRP3 inflammasome activation triggers severe inflammatory liver injury in N, N-dimethylformamide-exposed mice","volume":"929","author":"Zhang","year":"2024","journal-title":"Sci. Total Environ."},{"key":"B90","doi-asserted-by":"publisher","first-page":"e2415902","DOI":"10.1002\/advs.202415902","article-title":"Machine learning-driven prediction, preparation, and evaluation of functional nanomedicines via drug-drug self-assembly","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"B91","doi-asserted-by":"publisher","first-page":"109596","DOI":"10.1016\/j.biopha.2019.109596","article-title":"Vasoactive intestinal peptide suppresses the NLRP3 inflammasome activation in lipopolysaccharide-induced acute lung injury mice and macrophages","volume":"121","author":"Zhou","year":"2020","journal-title":"Biomed. Pharmacother."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1731165\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T06:39:40Z","timestamp":1764743980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1731165\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":91,"alternative-id":["10.3389\/fphar.2025.1731165"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1731165","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"article-number":"1731165"}}